Publications by authors named "Michelle Elliott"

Claim this Profile
A
Assessment of classical hematologists and classical hematology fellowship programs at NCI-designated cancer centers.
Lewis T Go, Lucas T Go, Madugodaralalage D S K Gunaratne, Alexandra P Wolanskyj-Spinner, Aneel A Ashrani, Michelle A Elliott

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia.
Sara K Silbert, Alexander W Rankin, Chloe N Hoang, Alexandra Semchenkova, Regina M Myers, Michelle Ann Elliott

Blood· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.
Naseema Gangat, Azeem Elbeih, Nour Ghosoun, Kristen McCullough, Fnu Aperna, Michelle Elliott

Am J Hematol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose IV ascorbic acid therapy for patients with CCUS with TET2 mutations.
Zhuoer Xie, Jenna Fernandez, Terra Lasho, Christy Finke, Michelle Amundson, Michelle Elliott

Blood· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspirin therapy is associated with a lower risk of pregnancy loss in both JAK2- and CALR-mutated essential thrombocythemia-A Mayo Clinic study of 200 pregnancies.
Naseema Gangat, Amritpal Singh, Rimal Ilyas, Giuseppe Gaetano Loscocco, Michelle Elliott

Am J Hematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases.
Faiqa Farrukh, Maymona Abdelmagid, Abhishek Mangaonkar, Mrinal Patnaik, Aref Al-Kali, Michelle A Elliott

Haematologica· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C3+ and C3- warm autoimmune hemolytic anemias: A comparison of clinical characteristics and treatment outcomes.
Jordan Nunnelee, Jithma Prasad Abeykoon, Aneel A Ashrani, Michelle Ann Elliott, C Christopher Hook

Eur J Haematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults.
Mark R Litzow, Zhuoxin Sun, Ryan J Mattison, Elisabeth M Paietta, Kathryn G Roberts, Michelle A Elliott

N Engl J Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.
Omer Karrar, Maymona Abdelmagid, Masooma Rana, Moazah Iftikhar, Kristen McCullough, Michelle A Elliott

Am J Hematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reappraisal of mast cell leukemia based on a single institution review of 16 cases: Mast cell morphology determines clinical outcome.
Animesh Pardanani, Ayalew Tefferi, Aref Al-Kali, Mrinal Patnaik, William J Hogan, Michelle A Elliott

Am J Hematol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mast cell cytomorphology and treatment outcome in mast cell leukemia.
Ayalew Tefferi, Animesh Pardanani, Aref Al-Kali, Hassan Alkhateeb, Kristen McCullough, Michelle A Elliott

Am J Hematol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One thousand patients with essential thrombocythemia: the Mayo Clinic experience.
Naseema Gangat, Omer Karrar, Aref Al-Kali, Kebede H Begna, Michelle A Elliott

Blood Cancer J· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib and daratumumab in refractory autoimmune hemolytic anemia.
John McGlothlin, Jithma Abeykoon, Eyad Al-Hattab, Aneel A Ashrani, Michelle Elliott

Am J Hematol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival.
Maymona G Abdelmagid, Aref Al-Kali, Kebede H Begna, William J Hogan, Mark R Litzow, Michelle A Elliott

Haematologica· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events.
Maymona G Abdelmagid, Aref Al-Kali, Mark R Litzow, Kebede H Begna, William J Hogan, Michelle A Elliott

Blood Cancer J· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blastphase myeloproliferative neoplasm.
Naseema Gangat, Rimal Ilyas, Kristen McCullough, Kebede H Begna, Aref Al-Kali, Michelle A Elliott

Haematologica· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases.
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref Al-Kali, Michelle A Elliott

Am J Hematol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).
Mostafa Abdallah, Kristen McCullough, Rimal Ilyas, Kebede H Begna, Aref Al-Kali, Michelle A Elliott

Blood Cancer J· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival.
Ayalew Tefferi, Amritpal Singh, Naseema Gangat, Aref Al-Kali, Hassan Alkhateeb, Michelle A Elliott

Haematologica· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience.
Ayalew Tefferi, Naseema Gangat, Mithun Shah, Hassan Alkhateeb, Mrinal S Patnaik, Michelle A Elliott

Haematologica· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site-specific venous thrombosis in essential thrombocythemia: Impact on subsequent vascular events and survival.
Naseema Gangat, Amritpal Singh, Natasha Szuber, Kebede Begna, Michelle Elliott

J Thromb Haemost· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide therapy for primary myelodysplastic syndromes with isolated del(5q): Determinants of response and survival in a real-world setting.
Amritpal Singh, Aref Al-Kali, James M Foran, Michelle A Elliott, Kebede Begna

Am J Hematol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy.
Ayalew Tefferi, Naseema Gangat, Aref Al-Kali, Hassan Alkhateeb, Mithun Shah, Michelle A Elliott

Am J Hematol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms.
Mithun Vinod Shah, Abhishek A Mangaonkar, Kebede H Begna, Hassan B Alkhateeb, Patricia Greipp, Michelle A Elliott

Blood Cancer J· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study.
Liewei Wang, Steven E Scherer, Suzette J Bielinski, Donna M Muzny, Leila A Jones, Michelle Elliott

Genet Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis